GlassScriptPhysician profile
Steven Howard Brown
NPI 1871555771
$2,348.41
in general payments reported to CMS, 2019-2025
24 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.50 · 2020: $89.49 · 2021: $414 · 2022: $575 · 2023: $745 · 2024: $283 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $493.89 | 2019-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $383.20 | 2020-2023 | Gattex, Entyvio |
| Medtronic, INC. | $223.91 | 2024-2025 | Interstim |
| Merz North America, INC. | $200.00 | 2023 | |
| Celgene Corporation | $115.05 | 2021-2023 | Zeposia |
| Abbvie INC. | $107.71 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $99.01 | 2021 | |
| Ironwood Pharmaceuticals, INC | $96.75 | 2022-2024 | Linzess |
| Exact Sciences Corporation | $90.94 | 2024-2025 | Cologuard Collection Kit |
| Ferring Pharmaceuticals INC. | $88.25 | 2021-2023 | Rebyota |
| Janssen Biotech, INC. | $77.76 | 2022-2023 | Stelara |
| Edwards Lifesciences Corporation | $58.12 | 2021 | |
| Olympus America INC. | $55.37 | 2020-2023 | Endoclot Phs, Single Use Electrosurgical Snare Sd-400 |
| Regeneron Healthcare Solutions, INC. | $43.32 | 2022-2023 | Dupixent |
| Gilead Sciences, INC. | $38.70 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $28.59 | 2019 | |
| Boston Scientific Corporation | $28.42 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.97 | 2022 | |
| Pentax of America, INC. | $18.35 | 2020 | |
| Masimo Corporation | $17.00 | 2021 | |
| Braintree Laboratories, INC. | $16.62 | 2024 | Sutab |
| Allergan, INC. | $15.36 | 2019 | |
| Thd America, INC. | $15.19 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.